Announcements

March 14, 2023

Genetics Signatures (ASX:GSS) – Investor Presentation

February 22, 2023

Genetics Signatures (ASX:GSS) – Half Yearly Report and Accounts

January 25, 2023

Genetics Signatures (ASX:GSS)- Notification of cessation of securities

December 9, 2022

Genetics Signatures (ASX:GSS) – Investor Webinar Presentation

View Announcement

October 29, 2022

Genetic Signatures (ASX:GSS) – Quarterly update and Appendix 4C

View Announcement

September 29, 2022

Genetics Signatures (ASX:GSS) – 3base® Kit for Antimicrobial Resistance

View Announcement

September 7, 2022

Genetics Signatures (ASX:GSS) – Investor Presentation

View Announcement

September 1, 2022

Genetics Signatures (ASX:GSS) – Appendix 4E – Preliminary Final Report

View Announcement

July 27, 2022

Genetics Signatures (ASX:GSS) – Quarterly update and Appendix 4C

View Announcement

July 26, 2022

Genetic Signatures (ASX:GSS) – Clinical Trial Recruitment Completed for US Enteric Kit

View Announcement